Archive ready

2024年12月期 第1四半期決算短信〔IFRS〕(連結)

https://ssl4.eir-parts.net/doc/2160/tdnet/2443431/00.pdf
May 4, 2026 at 11:20 AM JSTThe archive page, viewer, and downloads use this saved version.
May 4, 2026 at 11:20 AM JST·ssl4.eir-parts.net

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

2024年12月期 第1四半期決算短信〔IFRS〕(連結)

StartedMay 4, 2026 at 11:20 AM JST
File size0.29 MB
SHA-2566f5d112bc16c7cd09161a021f8adcc002b41d7f218ee5d4cf9bd321d6a8c680b
About this pageAI generated

This document is the quarterly financial report for the first quarter of the fiscal year ending December 2024, released by GNI Group, Inc. on May 15, 2024. The consolidated financial results show revenues of 5,948 million yen, operating profit of 2,283 million yen, and quarterly profit of 1,344 million yen, marking a 41.4% increase in revenue and a 474.4% increase in operating profit compared to the same period last year. The strong sales of the flagship product, Isurui, have significantly contributed to this growth, and there are expectations for future clinical trials and new product developments. Despite an uncertain economic environment, the company has achieved record-high performance.